<unk>  is a  that is FDA approved for the {{{indicationType}}} of primary hyperlipidemia and mixed dyslipidemia, regression of atherosclerotic disease in patients with a history of coronary artery disease (CAD) and hyperlipidemia, adjunct to diet to reduce elevated TC and LDL-C in adult patients with primary hyperlipidemia, reduce TG in adult patients with severe hypertriglyceridemia.   Common adverse reactions include flushing, diarrhea, nausea, vomiting, increased cough, and pruritus.
Niacin extended release
Atorvastatin calcium
Pioglitazone/Glimepiride
Sitagliptin And Metformin Hydrochloride
Pioglitazone And Metformin hydrochloride
Metformin
Buformin
Saxagliptin hydrochloride and Metformin hydrochloride